Literature DB >> 16885196

Polymorphisms in Th1-type cell-mediated response genes and risk of gastric cancer.

L Hou1, E M El-Omar, J Chen, P Grillo, C S Rabkin, A Baccarelli, M Yeager, S J Chanock, W Zatonski, L H Sobin, J Lissowska, J F Fraumeni, W H Chow.   

Abstract

Helicobacter pylori infection, the dominant risk factor for gastric cancers, has been shown to elicit T helper type 1 (Th1) polarized immunological responses. We conducted a population-based study of 305 gastric cancer cases and 427 age- and gender-matched controls in Warsaw, Poland, to evaluate the association with several variants in genes responsible for Th1-cell-mediated response. Genotyping was performed on genomic DNA by TaqMan(TM) assays to determine TNFA (-308 G>A, -417 G>A, -555 G>A, -1036 C>T, -1042 C>A, -1210 T>C), IL1A (-889 C>T), IFNGR2 (Ex7-128 T>C, Ex2-34 C>G and Ex2-16 A>G) and IL12A (IVS2-798 T>A, IVS2-701 C>A and Ex7+277 G>A) polymorphisms. We used unconditional logistic regression to estimate odds ratios (ORs) and 95% confidence intervals (CIs), adjusting for sex, age, education and smoking status. Out of six single nucleotide polymorphisms (SNPs) tested in TNFA, gastric cancer risk was significantly associated with the TNFA (-308 G>A) polymorphism, with ORs of 1.4 (95% CI: 1.0-2.0) for the G/A and 2.5 (95% CI: 1.3-4.9) for the A/A genotype carriers, when compared with the more frequent genotype (G/G) (P-trend < 0.001). Among the three tested SNPs in the IFNGR2 gene, only the Ex7-128C>T polymorphism was associated with increased risk, with ORs of 1.5 (95% CI: 1.0-2.3) for T/C and 1.7 (95% CI: 1.1-2.7) for C/C carriers when compared with T/T carriers (P-trend = 0.01). Subjects carrying both IFNGR2 Ex7-128 C/C and TNFA -308 A/A genotypes had the highest risk (OR = 5.5, 95% CI: 1.5-19.4), although the interaction was not statistically significant. IL1A (-889 C>T) and the three examined IL12A variants were unrelated to gastric cancer risk. Our findings suggest that two Th1-related polymorphisms (TNFA -308 A>G and IFNGR2 Ex7-128 C>T) may increase the risk of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16885196     DOI: 10.1093/carcin/bgl130

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  46 in total

1.  Polymorphisms in chemokine and receptor genes and gastric cancer risk and survival in a high risk Polish population.

Authors:  Andrew J Gawron; Angela J Fought; Jolanta Lissowska; Weimin Ye; Xiao Zhang; Wong-Ho Chow; Laura E Beane Freeman; Lifang Hou
Journal:  Scand J Gastroenterol       Date:  2010-11-22       Impact factor: 2.423

2.  Genetic variants in T helper cell type 1, 2 and 3 pathways and gastric cancer risk in a Polish population.

Authors:  Rajeev Mahajan; Emad M El-Omar; Jolanta Lissowska; Paolo Grillo; Charles S Rabkin; Andrea Baccarelli; Meredith Yeager; Leslie H Sobin; Witold Zatonski; Stephen J Channock; Wong-Ho Chow; Lifang Hou
Journal:  Jpn J Clin Oncol       Date:  2008-08-07       Impact factor: 3.019

3.  Contribution of IL12A and IL12B polymorphisms to the risk of cervical cancer.

Authors:  Andrzej Roszak; Adrianna Mostowska; Anna Sowińska; Margarita Lianeri; Pawel P Jagodziński
Journal:  Pathol Oncol Res       Date:  2012-05-22       Impact factor: 3.201

4.  GATA-3 augmentation down-regulates Connexin43 in Helicobacter pylori associated gastric carcinogenesis.

Authors:  Xiaoming Liu; Ke Cao; Canxia Xu; Tingzi Hu; Li Zhou; Dan Cao; Jing Xiao; Ling Luo; Yinjie Guo; Yong Qi
Journal:  Cancer Biol Ther       Date:  2015-04-22       Impact factor: 4.742

Review 5.  Helicobacter pylori and gastric cancer.

Authors:  Hidekazu Suzuki; Eisuke Iwasaki; Toshifumi Hibi
Journal:  Gastric Cancer       Date:  2009-06-27       Impact factor: 7.370

Review 6.  TNF-α-308 polymorphism and risk of digestive system cancers: a meta-analysis.

Authors:  Xu-Feng Guo; Jun Wang; Shi-Jie Yu; Jia Song; Meng-Yao Ji; Zhuo Cao; Ji-Xiang Zhang; Jing Wang; Wei-Guo Dong
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 7.  Gastric carcinogenesis.

Authors:  Jan Bornschein; Peter Malfertheiner
Journal:  Langenbecks Arch Surg       Date:  2011-05-25       Impact factor: 3.445

8.  Loss of gastrokine-2 drives premalignant gastric inflammation and tumor progression.

Authors:  Trevelyan R Menheniott; Louise O'Connor; Yok Teng Chionh; Jan Däbritz; Michelle Scurr; Benjamin N Rollo; Garrett Z Ng; Shelley Jacobs; Angelique Catubig; Bayzar Kurklu; Stephen Mercer; Toshinari Minamoto; David E Ong; Richard L Ferrero; James G Fox; Timothy C Wang; Philip Sutton; Louise M Judd; Andrew S Giraud
Journal:  J Clin Invest       Date:  2016-03-14       Impact factor: 14.808

9.  Polymorphisms of tumor necrosis factor-alpha are associated with increased susceptibility to gastric cancer: a meta-analysis.

Authors:  Jiyuan Zhang; Chao Dou; Yuting Song; Chaoneng Ji; Shaohua Gu; Yi Xie; Yumin Mao
Journal:  J Hum Genet       Date:  2008-03-19       Impact factor: 3.172

10.  The role of TNF genetic variants and the interaction with cigarette smoking for gastric cancer risk: a nested case-control study.

Authors:  Jae Jeong Yang; Kwang-Pil Ko; Lisa Y Cho; Aesun Shin; Jin Gwack; Soung-Hoon Chang; Hai-Rim Shin; Keun-Young Yoo; Daehee Kang; Sue K Park
Journal:  BMC Cancer       Date:  2009-07-17       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.